123 related articles for article (PubMed ID: 15054078)
1. NMDA receptor alterations in neurons from pediatric cortical dysplasia tissue.
André VM; Flores-Hernández J; Cepeda C; Starling AJ; Nguyen S; Lobo MK; Vinters HV; Levine MS; Mathern GW
Cereb Cortex; 2004 Jun; 14(6):634-46. PubMed ID: 15054078
[TBL] [Abstract][Full Text] [Related]
2. Immature neurons and GABA networks may contribute to epileptogenesis in pediatric cortical dysplasia.
Cepeda C; André VM; Wu N; Yamazaki I; Uzgil B; Vinters HV; Levine MS; Mathern GW
Epilepsia; 2007; 48 Suppl 5():79-85. PubMed ID: 17910585
[TBL] [Abstract][Full Text] [Related]
3. Pyramidal cell responses to gamma-aminobutyric acid differ in type I and type II cortical dysplasia.
André VM; Cepeda C; Vinters HV; Huynh M; Mathern GW; Levine MS
J Neurosci Res; 2008 Nov; 86(14):3151-62. PubMed ID: 18615638
[TBL] [Abstract][Full Text] [Related]
4. Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia?
Cepeda C; André VM; Vinters HV; Levine MS; Mathern GW
Epilepsia; 2005; 46 Suppl 5():82-8. PubMed ID: 15987258
[TBL] [Abstract][Full Text] [Related]
5. The NMDA receptor NR2B subunit contributes to epileptogenesis in human cortical dysplasia.
Möddel G; Jacobson B; Ying Z; Janigro D; Bingaman W; González-Martínez J; Kellinghaus C; Prayson RA; Najm IM
Brain Res; 2005 Jun; 1046(1-2):10-23. PubMed ID: 15890316
[TBL] [Abstract][Full Text] [Related]
6. Morphological and electrophysiological characterization of abnormal cell types in pediatric cortical dysplasia.
Cepeda C; Hurst RS; Flores-Hernández J; Hernández-Echeagaray E; Klapstein GJ; Boylan MK; Calvert CR; Jocoy EL; Nguyen OK; André VM; Vinters HV; Ariano MA; Levine MS; Mathern GW
J Neurosci Res; 2003 May; 72(4):472-86. PubMed ID: 12704809
[TBL] [Abstract][Full Text] [Related]
7. Cytomegalic interneurons: a new abnormal cell type in severe pediatric cortical dysplasia.
André VM; Wu N; Yamazaki I; Nguyen ST; Fisher RS; Vinters HV; Mathern GW; Levine MS; Cepeda C
J Neuropathol Exp Neurol; 2007 Jun; 66(6):491-504. PubMed ID: 17549009
[TBL] [Abstract][Full Text] [Related]
8. Epileptogenesis in pediatric cortical dysplasia: the dysmature cerebral developmental hypothesis.
Cepeda C; André VM; Levine MS; Salamon N; Miyata H; Vinters HV; Mathern GW
Epilepsy Behav; 2006 Sep; 9(2):219-35. PubMed ID: 16875879
[TBL] [Abstract][Full Text] [Related]
9. Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.
André VM; Cepeda C; Venegas A; Gomez Y; Levine MS
J Neurophysiol; 2006 Apr; 95(4):2108-19. PubMed ID: 16381805
[TBL] [Abstract][Full Text] [Related]
10. Postnatal switching of NMDA receptor subunits from NR2B to NR2A in rat facial motor neurons.
Xing GG; Wang R; Yang B; Zhang D
Eur J Neurosci; 2006 Dec; 24(11):2987-92. PubMed ID: 17156360
[TBL] [Abstract][Full Text] [Related]
11. Pediatric cortical dysplasia: correlations between neuroimaging, electrophysiology and location of cytomegalic neurons and balloon cells and glutamate/GABA synaptic circuits.
Cepeda C; André VM; Flores-Hernández J; Nguyen OK; Wu N; Klapstein GJ; Nguyen S; Koh S; Vinters HV; Levine MS; Mathern GW
Dev Neurosci; 2005; 27(1):59-76. PubMed ID: 15886485
[TBL] [Abstract][Full Text] [Related]
12. NMDA receptor composition differs among anatomically diverse malformations of cortical development.
Finardi A; Gardoni F; Bassanini S; Lasio G; Cossu M; Tassi L; Caccia C; Taroni F; LoRusso G; Di Luca M; Battaglia G
J Neuropathol Exp Neurol; 2006 Sep; 65(9):883-93. PubMed ID: 16957582
[TBL] [Abstract][Full Text] [Related]
13. Early postnatal switch in magnesium sensitivity of NMDA receptors in rat CA1 pyramidal cells.
Kirson ED; Schirra C; Konnerth A; Yaari Y
J Physiol; 1999 Nov; 521 Pt 1(Pt 1):99-111. PubMed ID: 10562337
[TBL] [Abstract][Full Text] [Related]
14. Increased numbers of coassembled PSD-95 to NMDA-receptor subunits NR2B and NR1 in human epileptic cortical dysplasia.
Ying Z; Bingaman W; Najm IM
Epilepsia; 2004 Apr; 45(4):314-21. PubMed ID: 15030493
[TBL] [Abstract][Full Text] [Related]
15. Impaired developmental switch of short-term plasticity in pyramidal cells of dysplastic cortex.
Chen HX; Xiang H; Roper SN
Epilepsia; 2007 Jan; 48(1):141-8. PubMed ID: 17241221
[TBL] [Abstract][Full Text] [Related]
16. Protection by cholesterol-extracting cyclodextrins: a role for N-methyl-D-aspartate receptor redistribution.
Abulrob A; Tauskela JS; Mealing G; Brunette E; Faid K; Stanimirovic D
J Neurochem; 2005 Mar; 92(6):1477-86. PubMed ID: 15748165
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of NMDA and AMPA receptor subunits in rat dorsal and ventral hippocampus.
Pandis C; Sotiriou E; Kouvaras E; Asprodini E; Papatheodoropoulos C; Angelatou F
Neuroscience; 2006 Jun; 140(1):163-75. PubMed ID: 16542781
[TBL] [Abstract][Full Text] [Related]
18. Kinetics and subunit composition of NMDA receptors in respiratory-related neurons.
Paarmann I; Frermann D; Keller BU; Villmann C; Breitinger HG; Hollmann M
J Neurochem; 2005 May; 93(4):812-24. PubMed ID: 15857385
[TBL] [Abstract][Full Text] [Related]
19. Possible protection by notoginsenoside R1 against glutamate neurotoxicity mediated by N-methyl-D-aspartate receptors composed of an NR1/NR2B subunit assembly.
Gu B; Nakamichi N; Zhang WS; Nakamura Y; Kambe Y; Fukumori R; Takuma K; Yamada K; Takarada T; Taniura H; Yoneda Y
J Neurosci Res; 2009 Jul; 87(9):2145-56. PubMed ID: 19224577
[TBL] [Abstract][Full Text] [Related]
20. Functional in vitro characterization of CR 3394: a novel voltage dependent N-methyl-D-aspartate (NMDA) receptor antagonist.
Losi G; Lanza M; Makovec F; Artusi R; Caselli G; Puia G
Neuropharmacology; 2006 Mar; 50(3):277-85. PubMed ID: 16236334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
